You’re offline. This is a read only version of the page.
Skip to main content
Educational Library
Toggle navigation
Home
EBMT Exam
EBMT Education
Search
MF Risk Calculator
Sign in
EBMT-EHA 6th European CAR T...
T-cell targeted therapies i...
T-cell targeted therapies in triple-class refractory multiple myeloma: sequence matters
Clinical Outcomes of Patients with Relapsed/Refractory Follicular Lymphoma Treated With Tisagenlecleucel: Phase 2 ELARA 3-Year Follow-up
Catherine Thieblemont
16/02/2024
Open Document
